Collegium gets U.S. commercial rights to Nucynta from Depomed

Depomed Inc. (NASDAQ:DEPO) granted Collegium Pharmaceutical Inc. (NASDAQ:COLL) exclusive, U.S. rights to commercialize its Nucynta tapentadol analgesic franchise, which includes Nucynta tapentadol im...